These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 31106482)
1. Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes. Wen L; Zhang Z; Peng R; Zhang L; Liu H; Peng H; Sun Y J Cell Biochem; 2019 Oct; 120(10):17520-17533. PubMed ID: 31106482 [TBL] [Abstract][Full Text] [Related]
2. RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models. Yang H; Zhang Z; Peng R; Zhang L; Liu H; Wang X; Tian Y; Sun Y Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779731 [TBL] [Abstract][Full Text] [Related]
3. Microarray analysis reveals long non‑coding RNA SOX2OT as a novel candidate regulator in diabetic nephropathy. Zhang X; Shang J; Wang X; Cheng G; Jiang Y; Liu D; Xiao J; Zhao Z Mol Med Rep; 2018 Dec; 18(6):5058-5068. PubMed ID: 30320339 [TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy. Chen S; Dong C; Qian X; Huang S; Feng Y; Ye X; Miao H; You Q; Lu Y; Ding D J Diabetes Complications; 2017 Mar; 31(3):569-576. PubMed ID: 28007334 [TBL] [Abstract][Full Text] [Related]
5. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy Chen W; Peng R; Sun Y; Liu H; Zhang L; Peng H; Zhang Z FASEB J; 2019 Oct; 33(10):11492-11506. PubMed ID: 31336052 [TBL] [Abstract][Full Text] [Related]
6. Whole transcriptome mapping reveals the lncRNA regulatory network of TFP5 treatment in diabetic nephropathy. Luo H; Yang L; Zhang G; Bao X; Ma D; Li B; Cao L; Cao S; Liu S; Bao L; E J; Zheng Y Genes Genomics; 2024 May; 46(5):621-635. PubMed ID: 38536617 [TBL] [Abstract][Full Text] [Related]
7. Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis. Zhao Z; Yan Q; Fang L; Li G; Liu Y; Li J; Pan S; Zhou S; Duan J; Liu D; Liu Z Comput Biol Med; 2023 Nov; 166():107480. PubMed ID: 37738894 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy Guo M; Dai Y; Jiang L; Gao J Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518 [TBL] [Abstract][Full Text] [Related]
9. An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy. Bai Z; Xie T; Liu T; Chen Z; Yu L; Zhang C; Luo J; Chen L; Zhao X; Xiao Y Front Endocrinol (Lausanne); 2022; 13():967822. PubMed ID: 36213291 [TBL] [Abstract][Full Text] [Related]
10. Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone. Zhang L; Zhou Y; Zhou F; Yu X; Liu J; Liu Y; Zhu Y; Wang W; Chen N Biomed Res Int; 2020; 2020():1360843. PubMed ID: 32025515 [TBL] [Abstract][Full Text] [Related]
11. Expression of long non‑coding RNA and mRNA in the hippocampus of mice with type 2 diabetes. Ci LY; Liu DS; Yang JQ; Liu YZ; Li CL; Zhang X; Ma CM; Hu RT Mol Med Rep; 2018 Dec; 18(6):4960-4968. PubMed ID: 30272307 [TBL] [Abstract][Full Text] [Related]
12. Transcriptome expression profiles associated with diabetic nephropathy development. Jing J; Song L; Zuo D; Li W; Sun Y; Ma X; Ren J Mol Cell Biochem; 2022 Jul; 477(7):1931-1946. PubMed ID: 35357607 [TBL] [Abstract][Full Text] [Related]
13. Glomerular expression pattern of long non-coding RNAs in the type 2 diabetes mellitus BTBR mouse model. Reichelt-Wurm S; Wirtz T; Chittka D; Lindenmeyer M; Reichelt RM; Beck S; Politis P; Charonis A; Kretz M; Huber TB; Liu S; Banas B; Banas MC Sci Rep; 2019 Jul; 9(1):9765. PubMed ID: 31278342 [TBL] [Abstract][Full Text] [Related]
14. RNA-Seq Analysis of ceRNA-Related Networks in the Regulatory Metabolic Pathway of Mice with Diabetic Nephropathy Subjected to Empagliflozin Intervention. Wu T; Zhang Z; Huang H; Wu X Arch Esp Urol; 2023 Nov; 76(9):680-689. PubMed ID: 38053423 [TBL] [Abstract][Full Text] [Related]
15. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy. Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721 [TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of transcriptome profiling of lncRNAs and mRNAs in livers of type 2 diabetes mellitus. Lan X; Han J; Wang B; Sun M Physiol Genomics; 2022 Feb; 54(2):86-97. PubMed ID: 35073196 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study. Yu T; Xu B; Bao M; Gao Y; Zhang Q; Zhang X; Liu R Front Endocrinol (Lausanne); 2022; 13():981100. PubMed ID: 36187128 [TBL] [Abstract][Full Text] [Related]
18. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3. Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428 [TBL] [Abstract][Full Text] [Related]
19. Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis. Shang J; Wang S; Jiang Y; Duan Y; Cheng G; Liu D; Xiao J; Zhao Z Sci Rep; 2019 Mar; 9(1):3328. PubMed ID: 30824724 [TBL] [Abstract][Full Text] [Related]
20. Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis. Li XQ; Ren ZX; Li K; Huang JJ; Huang ZT; Zhou TR; Cao HY; Zhang FX; Tan B Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]